Armata Pharmaceuticals, Inc. Common Stock

ARMPAMEX • USD
2.99 USD
↘ 0.88 (22.70%)🔴AT CLOSE (AS OF 08:15 PM EST)
🔴Market: CLOSED

Armata Pharmaceuticals, Inc. Common Stock (ARMP) is currently trading at $2.99. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (70.6%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 16, 2026.

Open?$3.84
High?$4.13
Low?$2.98
Prev. Close?$3.87
Volume?159.5K
Avg. Volume?88.1K
VWAP?$3.54
Rel. Volume?1.81x
Bid / Ask
Bid?$2.90 × 600
Ask?$3.23 × 100
Spread?$0.33
Midpoint?$3.07
Valuation & Ratios
Market Cap?143.9M
Shares Out?37.2M
Float?20.3M
Float %?55.2%
P/E Ratio?N/A
P/B Ratio?-0.83
EPS?-$3.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Employees
61
Market Cap
143.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1994-05-27
Address
5005 MCCONNELL AVE
LOS ANGELES, CA 90066
Phone: 310-665-2928
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
77
Short Sent.?
42
Piotroski F-Score?4/9Mixed
Altman Z-Score?-11.57Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?4.50%Low
Short Interest?912.6K
Days to Cover?9.8
Free Float20.3M
Avg Daily Volume93.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?0.12Weak
Quick Ratio?0.12Weak
Cash Ratio?0.10Low
Debt/Equity?-1.27Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-0.83CHEAP▾
P/S?
Peers
100
S&P
3
19.05HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-10.6CHEAP▾
EV/Sales?
Peers
100
S&P
3
45.94HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
94
70.6%STRONG▾
ROA?
S&P
3
-145.4%WEAK▾
Cash Flow & Enterprise
FCF?$-26861000
Enterprise Value?$347.1M
Fundamentals ratios updated end of day